Steve Miller - Chief Operating Officer, Catalyst Pharmaceuticals, Inc

As of August 26, 2021


Steve Miller Net Worth

  • Net worth is estimated to be at least $4.32M
  • Owns at least 741,724 units of Catalyst Pharmaceuticals, Inc stock
  • Sold an estimated value of $694.06K in the last 13 years at Catalyst Pharmaceuticals, Inc

Steve Miller Compensation at Catalyst Pharmaceuticals, Inc in 2018

  • Earned a $427,441409,325 salary and a $188 bonus
  • Rewarded $ in stock value and options
  • Received a total compensation of $

Steve Miller Trading

  • Largest purchase of shares was 120,000 units , worth over $374.4K on August 26, 2021
  • Largest sale of shares was 80,000 units , worth over $444.64K on August 26, 2021
  • In total has made about 23 transactions over 13 years
  • Usually trades in December and January, with the busiest year in 2014, 2016 and 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Steve Miller Mailing Address

  • Mailing address is 220 Miracle Mile Suite 234 Coral Gables FL 33134 FL

Catalyst Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Patrick J. McEnany 2018 $524,236 $332,063 $ $3,461,504 $3,461,504 $ $3,461,504
Steven R. Miller, COO and CSO 2018 $427,441409,325 $188,600 $ $1,655,195 $1,655,195 $11,000 $1,655,195
Gary Ingenito, CM&RO 2018 $399,373 $194,810 $ $1,666,645 $1,666,645 $26,192 $1,666,645
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1369568/000119312520188818/d932120ddef14a.htm

Catalyst Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 80,000 units sold on August 26, 2021 by Steve Miller worth over $444.64K
  • In the last 14 years, insiders at Catalyst Pharmaceuticals, Inc sold an estimated value of $5.01M and bought an estimated value of $11.77M
  • The most active traders are Patrick J McEnany, President and CEO,  Charles B. O'Keeffe, Director,  and Philip H Coelho, Director
  • Insider trading is most common in December, with the busiest year in 2008

CATALYST PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1